This global lifestyle and consumer packaged goods company expresses support for efforts by bipartisan lawmakers and industry stakeholders to establish clear federal regulations for hemp-derived THC products. The company advocates for a responsible, taxed framework that prioritizes consumer safety, encourages economic development, and aligns with public demand. It also endorses a federal regulatory baseline that allows states the flexibility to tailor implementation to local needs.
(Stock image generated with AI.)
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | MediPharm advances global reach in Q3 2025 with double-digit revenue growth and strong international medical cannabis gains
2 | Auxly reports 20 per cent net revenue increase in Q3 2025
3 | Charlotte’s Web advances clinical trials, expands botanical wellness portfolio in Q3 2025
4 | Canopy Growth reports Canada adult-use revenue up 30 per cent
Top Cannabis Stocks Nov. 7 to Nov. 13, 2025
1. T.TLRY | 3,523 views | Tilray Brands Inc.
2. T.CURA | 3,087 views | Curaleaf Holdings Inc.
3. T.LABS | 2,032 views | Medipharm Labs Corp.
4. T.WEED | 1,543 views | Canopy Growth Corp.
5. T.OGI | 436 views | Organigram Global Inc.
6. C.TGIF | 424 views | 1933 Industries Inc.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.